arrow
D

Dàlia Raϊch-Regué

Hospital del Mar Research Institute
H指数:22
被引数:1,352

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model

人源ACE2基因敲入小鼠模型能够重现SARS-CoV-2感染导致的呼吸系统紊乱,但避免了与转基因K18-hACE2模型相关的神经疾病。

MBIO
IF4.7
2025-05-140
OA
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial

异种SARS-CoV-2加强针(蛋白基PHH-1V疫苗)在IIb期试验中接种6个月后的体液和细胞免疫应答

VACCINE
IF3.5
2025-02-011
OAAI
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

Omicron XBB.1.16-适用于新型冠状病毒肺炎的疫苗: 临时免疫原性和安全性临床试验结果

2024-07-250
OAAI
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy

抗CD169人源化单克隆抗体的临床前开发作为广泛的抗病毒治疗策略

2024-06-010
OAAI
Plitidepsin as an Immunomodulator against Respiratory Viral Infections

Plitidepsin作为抗呼吸道病毒感染的免疫调节剂

2024-02-280
PRE
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

靶向受体结合基序大表面的单克隆抗体显示泛中和SARS-CoV-2活性

2024-02-056
OAAI
Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain
2023-10-026
OAAI
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

SARS-CoV-2重组蛋白RBD融合异二聚体疫苗的安全性和免疫原性

2023-09-296
OAAI
β-Cyclodextrins as affordable antivirals to treat coronavirus infection
2023-08-015
OAAI
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

基于蛋白质的PHH-1V与BNT162b2作为异源SARS-CoV-2加强疫苗在成人新型冠状病毒肺炎疫苗中的安全性和免疫原性比较: 多中心,随机,双盲,非劣效性IIb期试验

2023-05-0116
OA
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2

蓝藻病毒-N结合选择受体结合域外的SARS-CoV-2刺突寡糖并阻断SARS-CoV-2感染

2023-02-2813
OAAI
Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load
2022-11-2810
OAAI
Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution
2022-10-0624
OA
Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial
2022-06-2124
PRE
Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern

SARS-CoV-2抗原检测快速诊断测试对Omicron和其他相关变体的性能

2022-05-1018
OAAI
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
2022-05-0449
OAAI